文献速递乳腺US乳腺X线

当日乳腺活检项目对严重精神疾病患者活检时间差异的影响

Impact of a Same-Day Breast Biopsy Program on Disparities in Time to Biopsy for Patients With Serious Mental Illness.
PubMed 文献 · J Am Coll Radiol · 2022-01-01

该研究在学术乳腺影像中心比较实施当日活检(SDB)项目前后2.5年期间,严重精神疾病(SMI)患者与非SMI患者以及公共保险参保的年轻SMI患者(SMI-PP)与非SMI-PP患者之间活检完成时间及SDB比例的变化,发现干预前SMI-PP亚组存在SDB odds较低和活检时间较长的差异,干预后这些差异无证据,且全体患者SDB比例从15.3%升至36.09%。

要点

  • 干预前SMI-PP亚组SDB比例1/37(2.7%)低于非SMI-PP亚组47/296(15.88%),P=0.031。
  • 干预前SMI-PP亚组接受SDB的调整OR为0.13(95%CI 0.02-0.92,P=0.04),活检时间较长的调整OR为2.35(95%CI 1.26-4.37,P=0.01)。
  • 干预后SMI-PP亚组上述差异无证据,全体患者SDB比例从15.3%(310/2026)升至36.09%(852/2361),P<0.001。

核心结论

  • 当日乳腺活检项目可减轻SMI患者活检时间差异,并有助于改善该脆弱人群的乳腺癌诊疗公平性。

研究设计与样本

  • 研究为比较干预前后2.5年的分析,比较所有SMI患者与非SMI患者,以及公共保险参保的<65岁SMI患者(SMI-PP)与非SMI-PP患者;共纳入干预前2026例活检、干预后2361例活检;采用多变量比例优势模型和逻辑回归评估SMI状态、年龄、种族/民族、语言和保险与活检天数及SDB的关联。

诊断标准与关键数值

  • 干预前SMI患者SDB比例8.43%(7/83) vs 非SMI患者15.59%(303/1943),P=0.076。
  • 干预前SMI-PP亚组SDB比例2.7%(1/37) vs 非SMI-PP亚组15.88%(47/296),P=0.031。
  • 干预前调整年龄、种族/民族和语言后,SMI-PP亚组 vs 非SMI-PP亚组接受SDB的调整OR为0.13(95%CI 0.02-0.92,P=0.04),活检时间较长的调整OR为2.35(95%CI 1.26-4.37,P=0.01)。
  • 全体患者SDB比例从干预前15.3%(310/2026)升至干预后36.09%(852/2361),P<0.001。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to investigate disparities in time between breast biopsy recommendation and completion and the impact of a same-day biopsy (SDB) program for patients with serious mental illness (SMI), with a focus on more vulnerable individuals with public payer insurance.

METHODS: In August 2017, the authors' academic breast imaging center started routinely offering needle biopsies on the day of recommendation. Primary outcomes were the proportion of biopsies performed as SDBs and days from biopsy recommendation to completion over a 2.5-year pre- versus postintervention period, comparing all patients with SMI versus those without, and public payer-insured patients <65 years of age with SMI (SMI-PP) versus without SMI (non-SMI-PP). Multivariable proportional odds and logistic regression models were fit to assess association of SMI status, age, race/ethnicity, language, and insurance with days to biopsy and SDB within each period.

RESULTS: There were 2,026 biopsies preintervention and 2,361 biopsies postintervention. Preintervention, 8.43% of patients with SMI (7 of 83) underwent SDB compared with 15.59% of those without SMI (303 of 1,943) (P = .076), and 2.7% of the SMI-PP subgroup (1 of 37) underwent SDB compared with 15.88% of the non-SMI-PP subgroup (47 of 296) (P = .031). Adjusted for age, race/ethnicity, and language, disparities persisted in odds for undergoing SDB (adjusted odds ratio, 0.13; 95% confidence interval, 0.02-0.92; P = .04) and having longer days to biopsy (adjusted odds ratio, 2.35; 95% confidence interval, 1.26-4.37; P = .01) for the SMI-PP subgroup compared with the non-SMI-PP subgroup in the preintervention period. There was no evidence of these disparities postintervention for the SMI-PP subgroup. SDB proportion increased from 15.3% (310 of 2,026) to 36.09% (852 of 2,361) (P < .001) across all patients.

CONCLUSIONS: A same-day breast biopsy program mitigates disparities in time to biopsy for patients with SMI and helps improve breast cancer care equity for this vulnerable population.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Wang GX, Hwong AR, Mercaldo SF, et al. Impact of a Same-Day Breast Biopsy Program on Disparities in Time to Biopsy for Patients With Serious Mental Illness. J Am Coll Radiol. 2022. PMID: 35033303. doi:10.1016/j.jacr.2021.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。